1. Home
  2. ONCY vs STIM Comparison

ONCY vs STIM Comparison

Compare ONCY & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oncolytics Biotech Inc.

ONCY

Oncolytics Biotech Inc.

HOLD

Current Price

$0.88

Market Cap

112.5M

Sector

Health Care

ML Signal

HOLD

Logo Neuronetics Inc.

STIM

Neuronetics Inc.

HOLD

Current Price

$1.69

Market Cap

95.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONCY
STIM
Founded
1998
2003
Country
Canada
United States
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
112.5M
95.6M
IPO Year
2002
2018

Fundamental Metrics

Financial Performance
Metric
ONCY
STIM
Price
$0.88
$1.69
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
1
Target Price
$7.33
$3.00
AVG Volume (30 Days)
1.2M
1.7M
Earning Date
05-08-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
57.25
EPS
N/A
N/A
Revenue
N/A
$52,776,000.00
Revenue This Year
N/A
$11.10
Revenue Next Year
$2,505.00
$11.92
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.33
$0.80
52 Week High
$1.51
$4.84

Technical Indicators

Market Signals
Indicator
ONCY
STIM
Relative Strength Index (RSI) 39.38 58.99
Support Level $0.82 $1.23
Resistance Level $1.14 $1.80
Average True Range (ATR) 0.10 0.13
MACD -0.02 0.02
Stochastic Oscillator 10.17 87.88

Price Performance

Historical Comparison
ONCY
STIM

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer, among others.

About STIM Neuronetics Inc.

Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.

Share on Social Networks: